Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Cell Biosciences Launches New Platform for Multiplex Western Blot Detection

January 5, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Jan. 5, 2011 /- Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system....

BD Announces Webcast of Annual Meeting of Shareholders

January 5, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., Jan. 5, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, February 1, 2011, at 1 p.m. (ET). The webcast can be accessed from...

Hamilton CapTel® and Partner TV Ears to Display Telephone Communication Technology Designed for Individuals with Hearing Loss at Consumer Electronics Show

January 5, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

AURORA, Neb., Jan. 5, 2011 /- Consumer Electronics Show Las Vegas Convention Center Booth #2910. For the first time, Hamilton CapTel ® will demonstrate the CapTel 800i® captioned telephone for more than 100,000 attendees at the Consumer Electronics Show (CES) in Las Vegas...

Advertisement

ImmunGene Announces Multi-Target R & D Collaboration With Cephalon Australia for Interferon Payload Technology

January 5, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Jan. 5, 2011 /- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's...

Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection

January 4, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 5, 2011 /PRNewswire-Asia/ -- Dongsheng Pharmaceutical International Co., Ltd. (the "Company") (OTC Bulletin Board: DNGH ) announced today that it has obtained the exclusive sales rights of Thymosin Alpha 1 Injection in 19 provinces in China from Shanghai Biochemistry...

Managed Health Care Associates, Inc. (MHA) Acquires Navigator, Inc.

January 4, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

FLORHAM PARK, N.J., Jan. 4, 2011 /- Managed Health Care Associates, Inc. (MHA), a leading healthcare service company focused on alternate site providers, is pleased to announce the acquisition of Navigator, Inc., Nashville, TN. Navigator is one of the nation's largest and fastest growing...

Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients

January 4, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

BRYN MAWR, Pa., Jan. 4, 2011 /- Owner and medical director of Cirillo Cosmetic Dermatology Spa, Victoria A. Cirillo-Hyland, M.D., has expanded her practice and is now offering Pixel Perfect™ treatments to her patients with the purchase of the Pixel CO2 laser from Alma Lasers. "I'm...

NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference

January 4, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass., Jan. 4, 2011 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert S. Brown, Chief Financial Officer, will present at the 29th Annual J.P. Morgan...

Advertisement

Boston Scientific Completes Sale of Neurovascular Business

January 3, 2011 6:35 am | by Boston Scientific | News | Comments

Company prepays $600 million of debt

Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities

January 3, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

DETROIT, Jan. 3, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced that based on remediation efforts to date, it does not expect to commence the manufacture and distribution of products from its Detroit facility by the end of Caraco's Fiscal Year 2011, ending...

Lotus Pharmaceuticals Announces Approval of Reverse Stock Split

December 31, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the...

Sinovac's Stock Exchange Listing Moves to NASDAQ Global Select Market

December 31, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011.  The Company received...

CVS CAREMARK to Purchase Universal American's Medicare Part D Business

December 31, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Dec. 31, 2010 /- CVS Caremark (NYSE: CVS ) today announced it has entered into an agreement to acquire the Medicare Part D business of Universal American (NYSE: UAM ) for approximately $1.25 billion.  Universal American is a leading Medicare Prescription Drug...

Advertisement

Unilife Receives SPP Applications Exceeding A$12.8 Million

December 31, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Dec. 31, 2010 /- Unilife Corporation ( Unilife or Company ) (Nasdaq: UNIS ; ASX: UNS) announced today that its 2010 Share Purchase Plan ( SPP ), which closed on Wednesday, 22 December 2010, was significantly oversubscribed. The Company has received applications for...

Winner Medical Honored with Shenzhen Baoan District Quality Award

December 30, 2010 12:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 30, 2010 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical") a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced that it was...

Spectrum Control to Release Fourth Quarter and Fiscal Year 2010 Results; Host Conference Call on January 10, 2011

December 29, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

FAIRVIEW, Pa., Dec. 29, 2010 /- Spectrum Control, Inc. (Nasdaq: SPEC ), a leading designer and manufacturer of custom electronic products and systems, announced today that it will release its fourth quarter and fiscal year 2010 results on Monday, January 10, 2011, after the close of the...

CVS Caremark to Present at the 29th Annual J.P. Morgan Healthcare Conference

December 29, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Dec. 29, 2010 /- CVS Caremark Corporation (NYSE: CVS ) today announced that Larry Merlo, President and Chief Operating Officer, and Per Lofberg, Executive Vice President and President of Caremark Pharmacy Services, will be making a presentation to investors at the J.P....

MeridianRx Announces New Client

December 29, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

DETROIT, Dec. 29, 2010 /- MeridianRx is pleased to welcome Health Plan of Michigan as its newest client. Effective January 1, 2011, MeridianRx will handle processing and payment of prescription drug claims for the Health Plan of Michigan (HPM). HPM is the state's largest managed Medicaid...

Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe

December 29, 2010 6:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Outlook for Pharmaceuticals in Western Europe http://www.reportlinker.com/p0203107/The-Outlook-for-Pharmaceuticals-in-Western-Europe.html The countries of Western...

Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia

December 29, 2010 6:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Outlook for Pharmaceuticals in Central Asia http://www.reportlinker.com/p0203102/The-Outlook-for-Pharmaceuticals-in-Central-Asia.html The Outlook for Pharmaceutical...

Will New Year's Eve Revelers Make Merry In Your Medicine Cabinet?

December 29, 2010 6:37 am | by Bio-Medicine.Org | News | Comments

UPPER NYACK, N.Y., Dec. 29, 2010 /PRNewswire-USNewswire/ -- At New Year's Eve parties in homes around the country, party guests with drug dependencies will be scavenging through medicine cabinets looking for narcotics, anti-depressants, anti-psychotics, and anti-anxiety medications when...

Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012

December 29, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: E7: The Outlook for Pharmaceuticals to 2012 http://www.reportlinker.com/p0192576/E7-The-Outlook-for-Pharmaceuticals-to-2012.html E7: The Outlook for Pharmaceuticals to...

Globus Medical Announces 2,000th Patient Treated with TRANSITION® Stabilization System

December 29, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

AUDUBON, Pa., Dec. 29, 2010 /- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced that 2,000 patients have been treated with its TRANSITION® Stabilization System. TRANSITION, a semi-rigid system for lumbar fusion, incorporates...

Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry

December 29, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 29, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: 2010-2015 In-depth Research Report on China Sodium Fluoride Industry...

GenVec Forms Collaboration With World-Leading Animal Health Company

December 29, 2010 2:35 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., Dec. 29, 2010 /- GenVec, Inc. (Nasdaq: GNVC ) today announced that the company will be working with Merial to develop and commercialize GenVec's proprietary vaccine technology for use against foot-and-mouth disease (FMD). Merial is the leading FMD vaccine producer in...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading